In a phase I trial, intra-tumoral injection of Ad-mda-7, an adenovirus vector encoding IL-24, induced extensive apoptosis in tumor cells, yielding substantive clinical benefits in 44% of participants.95 The gene discussed is IL24; the disease is neoplasm.